About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COVID-19 Glycemic Control Study

NCT05977205·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Leiden University Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age ≥ 18 years
Diagnosed with type 1 or type 2 diabetes
Ability to perform fingerpricks
Sufficient comprehension of the Dutch language
Ability to fill out online questionnaires

You may not be if

Pregnancy
Newly diagnosed malignancy, with the exclusion of non-melanoma skin cancer, in the previous 6 months
Chemotherapy or immunotherapy for malignancy
Admission to hospital or rehabilitation center

The record

StatusCompleted

PhaseNo phase

Taking part492

StartedMay 2020

UpdatedAug 4, 2023

Conditions

Type 1 Diabetes Type 2 Diabetes

Where1

Leiden University Medical Center
Leiden, South Holland, Netherlands

Clareo Health | COVID-19 Glycemic Control Study